| Not Yet Recruiting | MEOP - Multidimensional Evaluations in Oncological Psychiatry NCT07406113 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients NCT06575530 | Beijing Shijitan Hospital, Capital Medical University | Phase 4 |
| Recruiting | Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) NCT06498167 | Universidade do Porto | — |
| Recruiting | Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery NCT07164300 | University of Ioannina | N/A |
| Withdrawn | Collaborative Nurse-pharmacist Counseling for Self-administered Biologics NCT05798104 | Tonia Carr | N/A |
| Unknown | QSPainRelief-STRAT NCT06244706 | Université Catholique de Louvain | N/A |
| Completed | A Study of GC101 TIL in Advanced Melanoma (BZ) NCT06120712 | Shanghai Juncell Therapeutics | Phase 1 / Phase 2 |
| Unknown | Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer NCT06152471 | Henrik Lindman | Phase 3 |
| Recruiting | Melatonin for Prevention of Kidney Injury NCT05084196 | Rutgers, The State University of New Jersey | Phase 3 |
| Completed | Oliceridine in Patients With Acute Burn Injuries NCT05465226 | University of Tennessee | Phase 4 |
| Recruiting | Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma NCT05717712 | Capital Medical University | Phase 1 |
| Recruiting | Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma NCT05717699 | Capital Medical University | Phase 1 |
| Recruiting | Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169 | University of Geneva, Switzerland | — |
| Completed | NUDGE-EHR Replication Trial at Mass General Brigham NCT05538065 | Brigham and Women's Hospital | N/A |
| Completed | A Phase I Study of GC101 TIL in Advanced Solid Tumors NCT05417750 | Shanghai Juncell Therapeutics | Phase 1 |
| Completed | Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MIN NCT05799053 | St. Antonius Hospital | Phase 3 |
| Completed | Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing NCT05402254 | Natalia Rodriguez Galan | N/A |
| Completed | Safety of Pediatric COVID-19 Vaccination NCT05157191 | Duke University | — |
| Completed | Simultaneous mRNA COVID-19 and IIV4 Vaccination Study NCT05028361 | Duke University | Phase 4 |
| Completed | Simultaneous RZV and aIIV4 Vaccination NCT05007041 | Duke University | Phase 4 |
| Unknown | Spread and Scale of a Polypharmacy App NCT04762303 | Centre for Innovation and Research in Aging, Canada | N/A |
| Completed | NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden NCT04740645 | Ferring Pharmaceuticals | — |
| Withdrawn | Implementation of a Pharmacist-led Pharmacogenomic Clinical Service NCT04984538 | Tabula Rasa HealthCare | — |
| Recruiting | Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extr NCT06607445 | Complejo Hospitalario Universitario de Badajoz | — |
| Unknown | Rheumatologic Adverse Events and Cancer Immunotherapy NCT04791150 | Poitiers University Hospital | N/A |
| Completed | Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers NCT05113472 | Respiralab | — |
| Unknown | Evaluating ActionADE in Reducing Adverse Drug Reactions NCT04568668 | University of British Columbia | N/A |
| Unknown | Evaluating ActionADE on Adverse Drug Event Due to Non-Adherence NCT04574648 | University of British Columbia | N/A |
| Completed | Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia NCT04770922 | Cipherome, Inc. | — |
| Unknown | Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil NCT04326504 | Fundação Bahiana de Infectologia | — |
| Recruiting | Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Ca NCT05800054 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Completed | Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus NCT05161741 | Getz Pharma | Phase 4 |
| Withdrawn | MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study) NCT04087109 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Unknown | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas NCT04635956 | Lei Li | Phase 2 |
| Completed | Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults NCT04284553 | Brigham and Women's Hospital | N/A |
| Completed | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. NCT05266300 | University of Southern Denmark | — |
| Unknown | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment NCT04378881 | Tabula Rasa HealthCare | — |
| Completed | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment NCT04339634 | Tabula Rasa HealthCare | — |
| Unknown | Drug-Related Problems in Neonatal Patients NCT04899960 | Hacettepe University | N/A |
| Unknown | Reducing Errors In The Neonatal Intensive Care Unit NCT04193839 | Fondazione Poliambulanza Istituto Ospedaliero | — |
| Withdrawn | Partnering With Patients for Improving Medication Safety During Transitions of Care: Implications for Work Sys NCT03544034 | Johns Hopkins University | N/A |
| Completed | Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED) NCT04181775 | Methodist Health System | — |
| Completed | Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) NCT03994302 | Groupe Hospitalier Pitie-Salpetriere | — |
| Completed | Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) NCT03947034 | Groupe Hospitalier Pitie-Salpetriere | — |
| Unknown | Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study NCT03640884 | Zhong Wang | — |
| Withdrawn | Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase NCT03791580 | RAND | N/A |
| Completed | Improving Wisely - Polypharmacy NCT03857100 | Johns Hopkins University | N/A |
| Completed | Impact of an Optimized Communication on the Readmission for Adverse Drug Event NCT03725046 | University Hospital, Montpellier | N/A |
| Unknown | Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification NCT03638726 | Dar El Oyoun Hospital | Phase 4 |
| Unknown | TIL and Anti-PD1 in Metastatic Melanoma NCT03638375 | Leiden University | Phase 1 / Phase 2 |
| Completed | Over-the-counter (OTC) Labels for Older Adults NCT04345731 | Michigan State University | N/A |
| Completed | A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status NCT03665402 | Seoul National University Hospital | N/A |
| Completed | Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients NCT03640273 | Thammasat University | Phase 2 |
| Completed | FLUAD® vs. Fluzone® High-Dose Study NCT03183908 | Duke University | Phase 4 |
| Completed | Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Inter NCT03272607 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Terminated | Pain Medication After Ambulatory Surgery NCT03135470 | Helsinki University Central Hospital | — |
| Unknown | Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population NCT04395326 | St. Justine's Hospital | — |
| Completed | Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elde NCT02906657 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization NCT02689076 | VA Office of Research and Development | N/A |
| Completed | Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Bloo NCT03112083 | Olympic Seafood AS | N/A |
| Suspended | Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study NCT02559960 | Zhong Wang | — |
| Completed | Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered NCT02969343 | Brigham and Women's Hospital | N/A |
| Completed | Medication Reconciliation in Comparison to an Extensive Medication Safety Check NCT02413957 | RWTH Aachen University | N/A |
| Completed | How Safe Are Our Pediatric Emergency Departments? NCT02162147 | Children's Hospital of Eastern Ontario | — |
| Completed | Ametop - Friend and Foe A Prospective Study of the Incidence of Adverse Reactions With Ametop NCT02750137 | KK Women's and Children's Hospital | — |
| Unknown | Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients NCT02324803 | Southern China Urology Cancer Consortium | Phase 2 |
| Completed | PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment NCT02864030 | Oncologia Medica dell'Ospedale Fatebenefratelli | Phase 4 |
| Completed | The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge. NCT01897870 | H.T. Ensing, PharmD, MSc | N/A |
| Completed | Post-License Safety Evaluation of Influenza Virus Vaccine NCT02136017 | Sichuan Center for Disease Control and Prevention | — |
| Completed | Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection NCT03808285 | Hospices Civils de Lyon | — |
| Completed | Adverse Drug Events at Emergency Department NCT03442010 | University Hospital, Montpellier | — |
| Completed | Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer NCT01080547 | Zhejiang University | Phase 3 |
| Completed | Preventing Adverse Drug Events With PatientSite NCT00140504 | Dana-Farber Cancer Institute | N/A |